Previous close | 120.40 |
Open | 121.20 |
Bid | 120.60 x 0 |
Ask | 120.80 x 0 |
Day's range | 121.20 - 121.20 |
52-week range | 91.00 - 122.60 |
Volume | |
Avg. volume | 5 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RAHWAY, N.J., May 09, 2024--Merck Provides Update on Phase 3 KEYNOTE-B21 Trial
RAHWAY, N.J., May 08, 2024--Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
RAHWAY, N.J., May 01, 2024--Merck Announces KEYNOTE-811 Trial Met Dual Primary Endpoint as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or GEJ Cancer